Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TKAT

Takung Art (TKAT)

Takung Art Co Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:TKAT
DateTimeSourceHeadlineSymbolCompany
12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
09/15/20146:55AMBusiness WireCardio3 BioSciences Receives Approval for the Continuation of Its CHART-1 Phase III Clinical Trial from the DSMBAMEX:TKATTakung Art Co Ltd
09/15/20146:55AMBusiness WireCARDIO3 BIOSCIENCES OBTIENT L’AUTORISATION DU DSMB POUR LA POURSUITE DE L’ETUDE CLINIQUE DE PHASE III CHART-1AMEX:TKATTakung Art Co Ltd
08/29/20146:03AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:TKATTakung Art Co Ltd
08/26/20146:01AMEdgar (US Regulatory)Amended Quarterly Report (10-q/a)AMEX:TKATTakung Art Co Ltd
08/25/20146:02AMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:TKATTakung Art Co Ltd
08/22/20149:10AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:TKATTakung Art Co Ltd
08/14/20141:18PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:TKATTakung Art Co Ltd
07/09/201411:04AMBusiness WireCardio3 BioSciences : PRÉCISION SUITE A LA DIFFUSION DU COMMUNIQUÉ DU 9 JUILLET À 12H00AMEX:TKATTakung Art Co Ltd
07/09/201411:04AMBusiness WireCardio3 BioSciences: Amendment to the Press Release Distributed on 9 July at 12.00 CETAMEX:TKATTakung Art Co Ltd
07/07/20145:00AMBusiness WireCardio3 BioSciences annonce l’inclusion de son 120ème patient dans l’étude clinique CHART-1AMEX:TKATTakung Art Co Ltd
07/07/20145:00AMBusiness WireCardio3 BioSciences to Enroll the 120th Patient for Its Chart-1 StudyAMEX:TKATTakung Art Co Ltd
07/01/20142:45AMBusiness WireCardio3 BioSciences annonce la clôture de son augmentation de capital de 25 millions d’euros à 44 euros par actionAMEX:TKATTakung Art Co Ltd
07/01/20142:45AMBusiness WireCardio3 BioSciences Announces Completion of its Capital Increase of €25 Million at €44 per shareAMEX:TKATTakung Art Co Ltd
06/16/20147:00AMBusiness WireCardio3 BioSciences annonce une augmentation de capital de 25 millions d’euros à 44 euros par actionAMEX:TKATTakung Art Co Ltd
06/16/20147:00AMBusiness WireCardio3 BioSciences s’allie avec Medisun International pour créer Cardio3 BioSciences Asia Holdings Ltd., Joint-Venture vo...AMEX:TKATTakung Art Co Ltd
06/16/20147:00AMBusiness WireCardio3 BioSciences Teams up with Medisun International to Create Cardio3 BioSciences Asia Holdings Ltd, a Joint Venture Aime...AMEX:TKATTakung Art Co Ltd
06/16/20147:00AMBusiness WireCardio3 BioSciences Announces a Capital Increase of €25 Million at €44 per shareAMEX:TKATTakung Art Co Ltd
06/10/201411:35AMBusiness WireCardio3 BioSciences reçoit l’autorisation de recruter des patients en Suède pour son étude clinique de phase III CHART-1AMEX:TKATTakung Art Co Ltd
06/10/201411:35AMBusiness WireCardio3 BioSciences Receives Authorization to Enroll Patients in Sweden in its Phase III Clinical Trial CHART-1AMEX:TKATTakung Art Co Ltd
06/05/201411:35AMBusiness WireCardio3 BioSciences nominée pour les « European Mediscience Awards » 2014AMEX:TKATTakung Art Co Ltd
06/05/201411:35AMBusiness WireCardio3 BioSciences Nominated for the European Mediscience Awards 2014AMEX:TKATTakung Art Co Ltd
06/02/201411:35AMBusiness WireCardio3 BioSciences Appoints Dr. Georges Rawadi as VP Business DevelopmentAMEX:TKATTakung Art Co Ltd
06/02/201411:35AMBusiness WireCardio3 BioSciences nomme Dr. Georges Rawadi au poste de Vice Président Business DevelopmentAMEX:TKATTakung Art Co Ltd
05/20/20141:52PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:TKATTakung Art Co Ltd
05/20/201411:35AMBusiness WireCARDIO3 BIOSCIENCES PUBLIE SON RAPPORT D’ACTIVITES AU 1er TRIMESRE 2014 ET CONFIRME SES PREVISIONS OPERATIONELLES ET FINANC...AMEX:TKATTakung Art Co Ltd
05/20/201411:35AMBusiness WireCardio3 BioSciences Announces Q1 2014 Business Update and Confirms Previous Operational and Financial GuidanceAMEX:TKATTakung Art Co Ltd
05/19/201411:35AMBusiness WireCardio3 BioSciences Signs First Sales Contract for C-Cathez®AMEX:TKATTakung Art Co Ltd
05/19/201411:35AMBusiness WireCardio3 BioSciences conclut son premier accord commercial pour son catheter C-Cathez®AMEX:TKATTakung Art Co Ltd
05/15/20146:05AMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)AMEX:TKATTakung Art Co Ltd
 Showing the most relevant articles for your search:AMEX:TKAT